In this respect, two targets have been explored so far: the cell surface membrane-bound glypican-3 (GPC3), a heparan sulfate proteoglycan protein, and the cell membrane-bound CD24, which is a mucin-like molecule that is overexpressed in a range of human carcinomas, including HCC [26]. Here, GPC3 is linked to hepatocellular carcinoma.